3 years 82.15
Extreme 82.15
101.02
5 years 69.36
Extreme 69.365
188.88
10 years 34.58
Extreme 34.58
325.12
Manager TitleAgeSince
Director of Finance/CFO 57 06/10/2017
Chief Tech/Sci/R&D Officer - -
Compliance Officer 48 01/01/2017
Date Insider Type Main position Quantity % Market Cap. Importance
8/14/25 A Issuer sale

Director

9,818 0.0300%
8/14/25 A Issuer sale

Director

9,818 0.0300%
8/14/25 A Issuer sale

Chief Executive Officer

520,347 1.5886%

Financials

2023 2024
Net sales 2.24B 2B 1.86B 1.69B 3.19B 216B 3.2B 22.36B 8.76B 110B 8.4B 8.21B 354B 2.35B 2.1B 1.95B 1.77B 3.35B 227B 3.37B 23.48B 9.2B 116B 8.82B 8.63B 372B
Net income -9.75M -8.71M -8.1M -7.37M -13.91M -943M -13.97M -97.46M -38.19M -481M -36.6M -35.8M -1.54B 43.23M 38.61M 35.92M 32.67M 61.68M 4.18B 61.95M 432M 169M 2.13B 162M 159M 6.85B
Net Debt - -
Logo Amedisys
Amedisys, Inc. is a healthcare service company. The Company is engaged in providing care and support in the home. It delivers clinically distinct care that suits its patients' needs, whether that is home-based recovery and rehabilitation after an operation or injury or care. Its operations involve serving patients across the United States through its three operating divisions: home health, hospice, and high acuity care. Its home health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The home health includes 346 care centers located in 34 states within the United States and the District of Columbia. Its hospice care is designed to provide comfort and support for those who are dealing with a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes.
Employees
19,000
Sector
-
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Ratings Surperformance© - Amedisys
  1. Stock Market
  2. Stocks
  3. AMED Stock